Chlamydia control in Europe – a survey of Member States, 2012

Chlamydia trachomatis (chlamydia) is a priority for infectious disease prevention and control in several European Union (EU) Member States. Chlamydia, the most commonly reported infection in the EU, affects mostly young heterosexual adults. Untreated chlamydia infection can cause a range of complications in the genital tract and increases the transmissibility of HIV infection. The first ECDC report on activities to control chlamydia in the EU and European Economic Area (EEA) Member States was issued in 2007. A 2009 ECDC document that guided Member States in developing national plans to control chlamydia infection was based on those findings. A technical report that summarises the most recent evidence about the population prevalence of chlamydia, the long-term complications of the infection, and the effectiveness and cost-effectiveness of chlamydia screening was published in 2014. The report that follows is part of the evaluation of chlamydia prevention and control activities in Europe. The report presents the second ECDC survey, which was carried out in 2012 to describe chlamydia prevention and control activities, changes in activities between 2007 and 2012, and suggests recommendations to improve chlamydia prevention and control in EU/EEA Member States

• Primary Source

ECDC: Health topics: Spotlight: Chlamydia http://www.ecdc.europa.eu/en/healthtopics/chlamydia/Pages/index.aspx

ECDC: Chlamydia control in Europe. Literature review, 2014 http://dx.publications.europa.eu/10.2900/16352

---